WAY-629

WAY-629 is a compound that is used in scientific research. It is a selective antagonist for the Epsilon receptor, which is a subtype of the GABA_A receptor. WAY-629 has sedative and anxiolytic effects in animal studies.

Pharmacology

WAY-629 is a selective antagonist for the epsilon subtype of the GABA_A receptor. This receptor is a type of ligand-gated ion channel that is activated by the neurotransmitter GABA. The epsilon subtype is less common than other subtypes of the GABA_A receptor, but it is thought to have a role in the sedative and anxiolytic effects of certain drugs.

In animal studies, WAY-629 has been found to have sedative and anxiolytic effects. It is thought to work by blocking the action of GABA at the epsilon subtype of the GABA_A receptor, thereby reducing the activity of this receptor.

Research

Research on WAY-629 and other epsilon antagonists is ongoing. These compounds may have potential for the development of new treatments for conditions such as anxiety disorders and insomnia.

See also

• GABA_A receptor
• Epsilon receptor
• Anxiety disorder
• Insomnia

WAY-629 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski